Dotbee.ai

Analysis Caribou Biosciences, Inc. (CRBU)

6/1/2024

Analysis Caribou Biosciences, Inc. (CRBU)

Analysis of Caribou Biosciences, Inc. (CRBU)

Caribou Biosciences, Inc. (CRBU) has been showing a downward trend in its stock price over the past few days. The Relative Strength Index (RSI) values have been consistently low, indicating an oversold condition. The Moving Average Convergence Divergence (MACD) indicator is also negative, suggesting a bearish momentum.

The stock has been trading below its Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) values, further confirming the bearish sentiment.

Overall, based on the technical indicators, Caribou Biosciences, Inc. seems to be in a bearish phase with potential for further downside. Traders and investors may consider exercising caution or implementing risk management strategies when dealing with CRBU stock.

Earnings

The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.

Main Statystic 🧠

The data provides detailed information about the financials, stock statistics, valuations metrics, stock price summary, and dividends and splits of a company.

1. Financials:
- Cash Flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance Sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- Profit Margin: 26.306%
- Fiscal Year Ends: September 30, 2023
- Income Statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.43, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating Margin: 30.743%
- Most Recent Quarter: March 31, 2024
- Return on Assets TTM: 22.073999%
- Return on Equity TTM: 147.25%

2. Stock Statistics:
- Short Ratio: 1.53
- Float Shares: 15,308,320,742
- Shares Short: 99,287,450
- Avg 10 Volume: 46,860,048
- Avg 90 Volume: 57,498,254
- Shares Outstanding: 15,334,099,968
- Percent Held by Insiders: 5.22%
- Percent Held by Institutions: 57.589%
- Short Percent of Shares Outstanding: 0.65%

3. Valuations Metrics:
- PEG Ratio: 26.319502
- Forward PE: 26.319502
- Trailing PE: 29.59409
- Enterprise Value: $2,950,762,332,160
- Price to Book MRQ: 39.3405
- Price to Sales TTM: 7.646095
- Enterprise to EBITDA: 22.763
- Enterprise to Revenue: 7.732
- Market Capitalization: $2,917,925,650,432

4. Stock Price Summary:
- Beta: 1.264
- Day 50 MA: $176.2646
- Day 200 MA: $181.0429
- Fifty-Two Week Low: $164.08
- Fifty-Two Week High: $199.62
- Fifty-Two Week Change: 6.853%

5. Dividends and Splits:
- Payout Ratio: 14.93%
- Dividend Date: May 16, 2024
- Last Split Date: August 31, 2020
- Ex-Dividend Date: May 10, 2024
- Last Split Factor: 4-for-1 split
- Forward Annual Dividend Rate: $1
- 5-Year Average Dividend Yield: 0.73%
- Forward Annual Dividend Yield: 0.5255%
- Trailing Annual Dividend Rate: $0.97
- Trailing Annual Dividend Yield: 0.5097%

Revenue estimate

The analysts' estimates for the future quarterly and annual sales of the company indicate a moderate growth trend.

For the current quarter ending on June 30, 2024, the average estimate is $77,545,400,000, representing a 2% increase from the same period last year. The number of analysts providing estimates is 25.

Looking at the next quarter ending on September 30, 2024, the average estimate is $85,501,800,000, with a sales growth of 3% compared to the previous year. The number of analysts remains at 25.

For the current fiscal year ending on September 30, 2024, the average estimate is $357,772,000,000, showing a 1% growth from the previous year. The number of analysts providing estimates for the annual sales is 38.

In the following fiscal year ending on September 30, 2025, the average estimate is $380,772,000,000, indicating a more significant growth of 6% from the current fiscal year. The number of analysts remains at 38.

Overall, the estimates suggest a steady growth trajectory for the company's sales in the upcoming quarters and years, with a slightly more optimistic outlook for the next fiscal year.

Growth estimates

Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:

1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.

These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. The company is expected to experience steady growth in the short term and maintain a healthy growth rate in the long term.

Price target

The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD

Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast of $200. However, it's important to note that there is a wide range of forecasts, from a low of $164 to a high of $250. The current price of $191.57 is below both the average and median forecast, suggesting that there may be potential for growth according to analysts.

Income statement 💸

Here are the revenue figures for the company over the past four fiscal years:

- 2020: $274,515,000,000
- 2021: $365,817,000,000
- 2022: $394,328,000,000
- 2023: $383,285,000,000

From these numbers, we can observe that the company has experienced a steady increase in revenue from 2020 to 2022, with a slight decrease in 2023. This trend indicates a generally positive growth trajectory for the company over the past few years.

Balance Sheet

These are balance sheets. Here are the conclusions based on the provided data:

1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,755,000,000.
2. Current assets fluctuate from year to year, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $217,350,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $302,083,000,000.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.

Overall, the company's assets and liabilities have been increasing over the years, while shareholders' equity has been fluctuating.

Cash Flow 💶

This is a cash flow statement. Here are some conclusions we can draw from the data:

1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.

Earnings estimate

The analysts' estimates for future quarterly and annual earnings per share are as follows:

1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.23
- Low Estimate: $1.18
- High Estimate: $1.26
- Year Ago EPS: $1.17
- Number of Analysts: 27

2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.42
- Low Estimate: $1.33
- High Estimate: $1.51
- Year Ago EPS: $1.35
- Number of Analysts: 26

3. Current Year (as of September 30, 2024):
- Average Estimate: $6.10
- Low Estimate: $5.95
- High Estimate: $6.41
- Year Ago EPS: $5.67
- Number of Analysts: 40

4. Next Year (as of September 30, 2025):
- Average Estimate: $6.69
- Low Estimate: $5.92
- High Estimate: $7.31
- Year Ago EPS: $6.10
- Number of Analysts: 40

Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates are increasing, which indicates potential growth in the company's profitability. However, it's important to consider that these are projections and actual results may vary.

MACD of CRBU

This is not investment advice. Remember to verify the information provided here.

Get access to the full analysis

  • Over 35 000 indexes
  • CFD, Forex, Crypto and Stocks Exchange
  • Over 150 Indicators
  • Pattern and candle analysis
  • Support and resistance levels
  • Fundamental, technical and sentimental analysis
  • Power from AI
Web versionApp StoreGoogle Play

Contacts

Telephone number

+48 32 700 81 66

Email address

[email protected]

Company information

Honey Payment Group S.A. at Al. Aleje Jerozolimskie 65 / 79, 00-697 Warsaw, Poland, Register number KRS 0000335507, NIP 5252859204, REGON 388760204. Honey Payment Group is listed on the Warsaw Stock Exchange (WSE) under the ticker symbol HPG. Link